Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old

We compared efavirenz pharmacokinetic (PK) parameters in children with tuberculosis (TB)/human immunodeficiency virus (HIV) coinfection on and off first-line antituberculosis therapy to that in HIV-infected children. Children 3 to 14 years old with HIV infection, with and without TB, were treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwara, Awewura, Yang, Hongmei, Antwi, Sampson, Enimil, Anthony, Gillani, Fizza S., Dompreh, Albert, Ortsin, Antoinette, Opoku, Theresa, Bosomtwe, Dennis, Sarfo, Anima, Wiesner, Lubbe, Norman, Jennifer, Alghamdi, Wael A., Langaee, Taimour, Peloquin, Charles A., Court, Michael H., Greenblatt, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325194/
https://www.ncbi.nlm.nih.gov/pubmed/30397066
http://dx.doi.org/10.1128/AAC.01657-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325194/
https://www.ncbi.nlm.nih.gov/pubmed/30397066
http://dx.doi.org/10.1128/AAC.01657-18

Ejemplares similares